MRM2 and schizophrenia: Notably, according to Jaffe et al. study (Jaffe et al., 2018), the MRM2 expression was also significantly decreased in the brains of schizophrenia patients compared with controls in the BrainSeq dataset (DLPFC, 155 cases and 196 controls, p = 6.09 × 10–4; data from http://eqtl.brainseq.org/phase1/sz/plots/ENSG00000122687), which was also replicated in the CommonMind Consortium dataset (DLPFC, 159 cases and 172 controls, p = 0.0223; data from http://eqtl.brainseq.org/phase1/sz/plots/ENSG00000122687), and in line with the results of eQTL analyses.